Company Overview and News

0
Newcrest’s gold hunt in northern Australia continues

2018-07-04 australianmining.com.au
Newcrest Mining has signed a farm-in agreement with Prodigy Gold over the Euro gold project in the Tanami region of the Northern Territory.
NCMGF ENR NCM NCMGY ABMMF ABU

1
ABM signs agreement with Newcrest

2018-05-08 businessnews.com.au
Gold miner Newcrest Mining has signed a heads of agreement to negotiate a farm-in deal with ABM Resources in relation to the Nedlands-based company’s Euro gold project in the Northern Territory.
NCMGF NCM NCMGY ABMMF ABU

1
ABM signs HOA with Newcrest

2018-05-08 businessnews.com.au
Gold miner Newcrest Mining has signed a heads of agreement to negotiate a farm-in deal with ABM Resources in relation to the Nedlands-based company’s Euro gold project in the Northern Territory.
NCMGF NCM NCMGY ABMMF ABU

4
Newcrest builds Tanami presence in search of gold discoveries

2018-05-08 australianmining.com.au
Newcrest Mining and ABM Resources will together advance exploration of the Euro gold project in the Tanami in Northern Territory after signing an agreement.
NCMGF ENR NCM NCMGY NEM ABMMF ABU

0
Ark Mines signs deal with ABM on Old Pirate gold mine in Tanami

2018-04-17 australianmining.com.au
Ark Mines has agreed to become the operator of the Old Pirate gold mine in Tanami, Northern Territory following an agreement with owner ABM Resources. Ark Mines will pay $2.2 million to ABM — attempting to tighten up its NT gold interests — in cash and bonds and has also agreed to a 2.5 per cent net smelter royalty (NSR) on gold sales above $5 million.
ABMMF AHK ABU

0
St Barbara takes 12.3% stake in Duketon Mining

2018-04-05 australianmining.com.au
Australian gold exploration and production company St Barbara has paid $4 million for 14.5 million shares of Duketon Mining at a price of 27.5 cents per share, representing a 12.3 per cent investment in the company.
DKM CYL SBM ABMMF SMP PEX ABU

0
Duketon Mining surges after St Barbara Ltd’s $4 million investment in gold-nickel strategy

2018-04-04 proactiveinvestors.com.au
Duketon Mining Ltd (ASX:DKM) has surged to a new 12-month high of 30 cents on news of a $4 million investment by mid-tier gold producer St Barbara Ltd (ASX:SBM).
DKM CYL SBM ABMMF PEX ABU

0
St Barbara invests in ABM

2018-03-15 businessnews.com.au
Gold miner St Barbara has taken a 10 per cent stake in local explorer ABM Resources as part of its recently announced $6 million capital raising.
SBM ABMMF ABU

18
ASX extends losing streak to three days as banks retreat on inquiry spotlight

2018-03-15 theage.com.au
Australian shares fell for the third straight session as banks wilted under the spotlight of the Hayne inquiry.
PLS ASXFF PMV PILBF RIO RIO SRHYY ABMMF OGFGY ABU SYAAF RTPPF ASXFY RIO SYR RTNTF SBM OGFGF ORG

17
ASX extends losing streak to three days as banks retreat on inquiry spotlight

2018-03-15 smh.com.au
Australian shares fell for the third straight session as banks wilted under the spotlight of the Hayne inquiry.
PLS ASXFF PMV PILBF RIO RIO SRHYY ABMMF OGFGY ABU SYAAF RTPPF ASXFY RIO SYR RTNTF SBM OGFGF ORG

0
St Barbara secures 10% stake in ABM

2018-03-14 australianmining.com.au
Gold miner St Barbara has taken a 10 per cent share in ASX-listed junior ABM Resources, which is raising funds to execute an exploration program in the Tanami district.
SBM ABMMF IGO IIDDY ABU

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

Silicon Investor Message Boards

This table lists all message boards related to ASX:ABU / ABM RESOURCES NL on message board site Silicon Investor.

POT-Weed-MJ-Cannabus- Stocks CBGI Cannabusiness Group
Donu0027t abuse it, reuse it! ARCI makes the big comeback. REPORTING ABUSIVE MARKET MAKING ACTIVITIES
Righthaven - Abusive Shareholder Abuse and Defences against
E*Trade: abuses u0026 excuses SAU (Substance Abuse Technologies)
LIST OF COs. THAT MAY HAVE ABUSED ACQUIRED Ru0026D WRITEOFFS Kookaburra Res KOB - TSE